Role of coerulean noradrenergic neurones in general anaesthesia in rats

British Journal of Anaesthesia

Volumn 107, Issue 6, 2011, Pages 924-929

  Kushikata, T ^a   Yoshida, H ^a   Kudo, M ^a   Kudo, T ^a,a   Hirota, K ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

anaesthesia, duration; anaesthesia, general; anaesthetics i.v.; brain, central monoamines

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; KETAMINE; THIOPENTAL;

ANALGESIA; ANESTHESIA INDUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; COERULEUS NORADRENERGIC NEURON; GENERAL ANESTHESIA; MALE; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; RAT;

EID: 81855183846     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer303     Document Type: Article

References (34)

1. Berridge CW. Noradrenergic modulation of arousal. Brain Res Rev 2008; 58: 1-17
2. Tanaka M, Yoshida M, Emoto H, Ishii H. Norepinephrine systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur J Pharmacol 2000; 405: 397-406
3. Kreibich A, Reyes BA, Curtis AL, et al. Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system. J Neurosci 2008; 28: 6516-25
4. Van Bockstaele EJ, Reyes BA, Valentino RJ. The locus coeruleus: a key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res 2010; 1314: 162-74
5. Aston-Jones G. Brain structures and receptors involved in alertness. Sleep Med 2005; 6(Suppl. 1): S3-7
6. Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 2009; 10: 211-23
7. Xanthos DN, Bennett GJ, Coderre TJ. Norepinephrine-induced nociception and vasoconstrictor hypersensitivity in rats with chronic post-ischemia pain. Pain 2008; 137: 640-51
8. Kubota T, Anzawa N, Hirota K, Yoshida H, Kushikata T, Matsuki A. Effects of ketamine and pentobarbital on norepinephrine release from the medial prefrontal cortex in rats. Can J Anaesth 1999; 46: 388-92
9. Yoshida H, Kushikata T, Tose R, Kudo M, Kudo T, Hirota K. Nitrous oxide and xenon increase norepinephrine release in the cerebral cortex in vivo and in vitro. Neurosci Lett 2010; 469: 199-203
10. Tose R, Kushikata T, Yoshida H, et al. Orexin A decreases ketamine-induced anesthesia time in the rat: the relevance to brain noradrenergic neuronal activity. Anesth Analg 2009; 108: 491-5
11. Kubota T, Hirota K, Anzawa N, Yoshida H, Kushikata T, Matsuki A. Physostigmine antagonizes ketamine-induced norepinephrine release from the medial prefrontal cortex in rats. Brain Res 1999; 840: 175-8
12. Tomemori N, Komatsu T, Shingu K, Urabe N, Seo N, Mori K. Activation of the supraspinal pain inhibition system by ketamine hydrochloride. Acta Anaesthesiol Scand 1981; 25: 355-9
13. Crisp T, Perrotti JM, Smith DL, Stafinsky JL, Smith DJ. The local monoaminergic dependency of spinal ketamine. Eur J Pharmacol 1991; 194: 167-72
14. Kudo T, Kushikata T, Kudo M, Kudo T, Hirota K. A central neuropathic pain model by DSP-4 induced lesion of noradrenergic neurons: preliminary report. Neurosci Lett 2010; 481: 102-4
15. Fyfe LW, Cleary DR, Macey TA, Morgan MM, Ingram SL. Tolerance to the antinociceptive effect of morphine in the absence of shortterm presynaptic desensitization in rat periaqueductal gray neurons. J Pharmacol Exp Ther 2010; 335: 674-80
16. Heidari MR, Foroumadi A, Amirabadi A, Samzadeh-Kermani A, Azimzadeh BS, Eskandarizadeh A. Evaluation of anti-inflammatory and analgesic activity of a novel rigid 3, 4-dihydroxy chalcone in mice. Ann N Y Acad Sci 2009; 1171: 399-406
17. Fritschy JM, Grzanna R. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system? Prog Brain Res 1991; 88: 257-68
18. Fritschy JM, Grzanna R. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neuroscience 1989; 30: 181-97
19. Fukui M, Takishita A, Zhang N, Nakagawa T, Minami M, Satoh M. Involvement of locus coeruleus noradrenergic neurons in supraspinal antinociception by alpha,beta-methylene-ATP in rats. J Pharmacol Sci 2004; 94: 153-60
20. Kushikata T, Hirota K, Yoshida H, Kubota T, Ishihara H, Matsuki A. Alpha-2 adrenoceptor activity affects propofol-induced sleep time. Anesth Analg 2002; 94: 1201-6
21. Mason ST, King RA, Banks P, Angel A. Brain norepinephrine and naesthesia: behavioural and electrophysiological evidence. Neuroscience 1983; 10: 177-85
22. Hirota K, Kushikata T. Central noradrenergic neurones and the mechanism of general anaesthesia. Br J Anaesth 2001; 87: 811-3
23. Minzenberg MJ, Watrous AJ, Yoon JH, Ursu S, Carter CS. Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI. Science 2008; 322: 1700-2
24. Curtis AL, Lechner SM, Pavcovich LA, Valentino RJ. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J Pharmacol Exp Ther 1997; 281: 163-72
25. Palamarchouk VS, Zhang J, Zhou G, Swiergiel AH, Dunn AJ. Hippocampal norepinephrine-like voltammetric responses following nfusion of corticotropin-releasing factor into the locus coeruleus. Brain Res Bull 2000; 51: 319-26
26. Berridge CW, Foote SL. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. J Neurosci 1996; 16: 6999-7009
27. Lin Y, Quartermain D, Dunn AJ, Weinshenker D, Stone EA. Possible dopaminergic stimulation of locus coeruleus alpha1-adrenoceptors involved in behavioral activation. Synapse 2008; 62: 516-23
28. Kelz MB, Sun Y, Chen J, et al. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci USA 2008; 105: 1309-14
29. Ossipov MH, Kovelowski CJ, Nichols ML, Hruby VJ, Porreca F. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat. Pain 1995; 62: 287-93
30. Kawamata T, Omote K, Sonoda H, Kawamata M, Namiki A. Analgesic mechanisms of ketamine in the presence and absence of peripheral inflammation. Anesthesiology 2000; 93: 520-8
31. Lu J, Nelson LE, Franks N, Maze M, Chamberlin NL, Saper CB. Role of endogenous sleep-wake and analgesic systems in anesthesia. J Comp Neurol 2008; 508: 648-62
32. Zhang C, Davies MF, Guo TZ, Maze M. The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord. Anesthesiology 1999; 91: 1401-7
33. Zhang Y, Eger EI II, Dutton RC, Sonner JM. Inhaled anesthetics have hyperalgesic effects at 0.1 minimum alveolar anesthetic concentration. Anesth Analg 2000; 91: 462-6
34. Rowley TJ, Daniel D, Flood P. The role of adrenergic and cholinergic transmission in volatile anesthetic-induced pain enhancement. Anesth Analg 2005; 100: 991-5